Search





Search





Markets
/
Stocks
/
bdtx
/

Black Diamond Therapeutics Inc

BDTX

Add to Watchlist

1.690USD

-0.025-1.46%

Close 07-31 16:00（ET）Quotes delayed by 15 min

96.84MMarket Cap

LossP/E TTM

Black Diamond Therapeutics Inc

1.690

-0.025-1.46%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

BDTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Black Diamond Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-119.16%-10.23M

54.92%-6.79M

30.67%-7.85M

37.80%-9.16M

351.95%53.41M

-7.87%-15.05M

38.33%-11.32M

-2.49%-14.73M

-5.83%-21.20M

36.39%-13.96M

-11.45%-18.36M

20.47%-14.37M

29.96%-20.03M

8.76%-21.94M

37.78%-16.48M

28.21%-18.07M

-16.95%-28.60M

-52.44%-24.05M

-130.56%-26.48M

-85.49%-25.16M

-116.05%-24.45M

-110.01%-15.77M

-119.62%-11.49M

-171.34%-13.57M

-64.57%-11.32M

-215.06%-7.51M

-181.79%-5.23M

---5.00M

---6.88M

---2.38M

---1.86M

Net income from continuing operations

-115.98%-9.04M

5.44%-15.12M

45.38%-8.50M

46.95%-10.56M

410.24%56.54M

17.64%-15.98M

32.38%-15.56M

-3.95%-19.91M

12.69%-18.23M

7.92%-19.41M

-6.25%-23.01M

16.48%-19.15M

18.16%-20.88M

18.51%-21.08M

38.27%-21.65M

33.25%-22.93M

15.82%-25.51M

-14.32%-25.87M

-95.83%-35.08M

-135.75%-34.35M

-149.49%-30.30M

-129.12%-22.63M

-93.31%-17.91M

-18.59%-14.57M

-217.27%-12.14M

-222.08%-9.88M

-292.63%-9.27M

---12.29M

---3.83M

---3.07M

---2.36M

Operating gains losses

-68.97%27.00K

8622.35%7.41M

0.00%86.00K

1.16%87.00K

-1.16%85.00K

-25.22%86.00K

-24.56%86.00K

-29.51%86.00K

-31.75%86.00K

-10.85%115.00K

-10.94%114.00K

-2.40%122.00K

2.44%126.00K

200.00%129.00K

540.00%128.00K

557.89%125.00K

720.00%123.00K

207.14%43.00K

53.85%20.00K

90.00%19.00K

66.67%15.00K

7.69%14.00K

0.00%13.00K

-16.67%10.00K

-25.00%9.00K

18.18%13.00K

--13.00K

--12.00K

--11.00K

Other non-cash items

8.47%384.00K

1612.12%565.00K

283.46%499.00K

197.01%357.00K

273.53%354.00K

134.74%33.00K

-225.35%-272.00K

-151.18%-368.00K

-125.53%-204.00K

-112.48%-95.00K

-71.78%217.00K

-12.10%719.00K

-12.96%799.00K

-28.41%761.00K

-28.13%769.00K

-19.73%818.00K

-11.82%918.00K

-64.28%1.06M

369.52%1.07M

388.67%1.02M

2114.89%1.04M

--2.98M

---397.00K

---353.00K

--47.00K

----

--0.00

Change in working capital

41.94%-3.05M

-21.08%-988.00K

-167.65%-1.68M

-470.97%-805.00K

-15.12%-5.26M

-120.79%-816.00K

99.52%2.48M

-83.37%217.00K

-64.06%-4.57M

184.17%3.92M

-22.97%1.24M

97.13%1.30M

62.92%-2.79M

-70.74%-4.66M

-63.96%1.61M

-81.55%662.00K

-543.65%-7.51M

-293.00%-2.73M

-7.07%4.47M

4884.00%3.59M

252.80%1.69M

932.35%1.42M

133.84%4.81M

-104.21%-75.00K

64.86%-1.11M

-127.64%-170.00K

318.09%2.06M

--1.78M

---3.15M

--615.00K

--492.00K

-Change in prepaid expenses

-35.84%-921.00K

-198.43%-251.00K

-48.76%475.00K

159.66%105.00K

30.32%-678.00K

60.38%255.00K

37.95%927.00K

-116.75%-176.00K

-354.05%-973.00K

-91.62%159.00K

-22.85%672.00K

17.17%1.05M

114.46%383.00K

254.77%1.90M

9.84%871.00K

694.04%897.00K

5.60%-2.65M

147.30%535.00K

98.25%793.00K

-113.25%-151.00K

27.10%-2.81M

-50.00%-1.13M

1150.00%400.00K

27.66%1.14M

-222.01%-3.85M

-25033.33%-754.00K

433.33%32.00K

--893.00K

---1.20M

---3.00K

--6.00K

-Change in other current assets

0.00%44.00K

113.06%44.00K

--44.00K

---337.00K

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

1100.00%10.00K

-100.00%0.00

0.00%6.00K

692.86%83.00K

91.67%-1.00K

300.00%2.00K

130.00%6.00K

72.55%-14.00K

---12.00K

-200.00%-1.00K

-25.00%-20.00K

-5000.00%-51.00K

100.00%0.00

--1.00K

---16.00K

---1.00K

---2.00K

-Change in other current liabilities

----

-100.00%0.00

100.00%0.00

-100.00%0.00

84.85%-190.00K

-85.22%175.00K

-1455.71%-949.00K

156.47%964.00K

-214.21%-1.25M

610.34%1.18M

--70.00K

---1.71M

--1.10M

---232.00K

Cash from non-recurring investing activities

Cash from operating activities

-119.16%-10.23M

54.92%-6.79M

30.67%-7.85M

37.80%-9.16M

351.95%53.41M

-7.87%-15.05M

38.33%-11.32M

-2.49%-14.73M

-5.83%-21.20M

36.39%-13.96M

-11.45%-18.36M

20.47%-14.37M

29.96%-20.03M

8.76%-21.94M

37.78%-16.48M

28.21%-18.07M

-16.95%-28.60M

-52.44%-24.05M

-130.56%-26.48M

-85.49%-25.16M

-116.05%-24.45M

-110.01%-15.77M

-119.62%-11.49M

-171.34%-13.57M

-64.57%-11.32M

-215.06%-7.51M

-181.79%-5.23M

---5.00M

---6.88M

---2.38M

---1.86M

Investing cash flow

Net cash from continuing investing activities

100.00%0.00

62.50%-3.00K

97.92%-1.00K

73.68%-10.00K

---13.00K

---8.00K

-245.45%-48.00K

60.00%-38.00K

----

100.00%0.00

512.50%33.00K

-149.22%-95.00K

-100.00%0.00

-102.70%-9.00K

-100.54%-8.00K

-77.24%193.00K

-82.50%7.00K

205.50%333.00K

18512.50%1.49M

3292.00%848.00K

--40.00K

5350.00%109.00K

-27.27%8.00K

1350.00%25.00K

-100.00%0.00

-60.00%2.00K

10.00%11.00K

---2.00K

--10.00K

--5.00K

--10.00K

Capital expenditures

----

--0.00

--33.00K

-100.00%0.00

----

-77.24%193.00K

-82.50%7.00K

205.50%333.00K

7103.03%2.38M

3292.00%848.00K

--40.00K

5350.00%109.00K

200.00%33.00K

--25.00K

-100.00%0.00

-60.00%2.00K

10.00%11.00K

----

--10.00K

--5.00K

--10.00K

Net cash flow from disposal of fixed assets

100.00%0.00

62.50%-3.00K

97.92%-1.00K

73.68%-10.00K

---13.00K

---8.00K

-245.45%-48.00K

60.00%-38.00K

----

100.00%0.00

512.50%33.00K

-149.22%-95.00K

-100.00%0.00

-102.70%-9.00K

-100.54%-8.00K

-77.24%193.00K

-82.50%7.00K

205.50%333.00K

18512.50%1.49M

3292.00%848.00K

--40.00K

5350.00%109.00K

-27.27%8.00K

1350.00%25.00K

-100.00%0.00

-60.00%2.00K

10.00%11.00K

---2.00K

--10.00K

--5.00K

--10.00K

Net cash flow from investment products

128.50%19.50M

-110.42%-2.89M

300.42%8.59M

-8527.78%-59.16M

162.14%8.53M

126.64%27.76M

105.67%2.15M

-95.89%702.00K

-155.37%-13.73M

429.57%12.25M

-361.06%-37.85M

-14.60%17.08M

48.22%24.81M

-94.69%2.31M

-61.01%14.50M

-59.22%20.00M

376.27%16.74M

766.39%43.58M

707.51%37.19M

117.54%49.05M

--3.51M

---6.54M

--4.61M

---279.62M

----

Net cash flow from other investing activities

--0.00

----

--25.00K

---10.00K

----

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

128.15%19.50M

-110.40%-2.89M

291.70%8.59M

-8093.65%-59.15M

162.23%8.55M

126.70%27.77M

105.79%2.19M

-95.69%740.00K

-155.37%-13.73M

427.52%12.25M

-361.14%-37.88M

-13.29%17.18M

48.28%24.81M

-94.63%2.32M

-59.36%14.51M

-58.90%19.81M

381.55%16.73M

750.45%43.24M

676.53%35.70M

117.24%48.20M

--3.47M

-29004.35%-6.65M

21990.48%4.60M

-13982100.00%-279.64M

100.00%0.00

560.00%23.00K

-110.00%-21.00K

--2.00K

---10.00K

---5.00K

---10.00K

Financing cash flow

Cash flow from continuous financing activities

-678.13%-185.00K

-167.35%-196.00K

153.17%134.00K

-100.54%-116.00K

-99.23%32.00K

732.61%291.00K

-100.35%-252.00K

--21.38M

7998.04%4.13M

-64.29%-46.00K

138221.15%71.93M

--0.00

-66.67%51.00K

---28.00K

-18.75%52.00K

-100.00%0.00

-68.19%153.00K

-100.00%0.00

-76.30%64.00K

--184.00K

-99.78%481.00K

-99.01%830.00K

-99.39%270.00K

100.00%0.00

--213.84M

76.43%83.50M

787.53%44.26M

---70.00K

--0.00

--47.33M

--4.99M

Net cash flow from debt Issuance/repayment

----

--0.00

----

--0.00

Net cash flow from common stock issuance/repurchase

----

--0.00

100.00%0.00

-100.00%0.00

--0.00

-100.70%-500.00K

--21.01M

--3.98M

--0.00

--71.85M

----

--0.00

-100.00%0.00

--0.00

--213.84M

----

--0.00

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

----

79.25%84.83M

795.71%44.67M

----

--47.33M

--4.99M

Proceeds from stock option exercised by employees

-678.13%-185.00K

-167.35%-196.00K

-45.97%134.00K

-131.87%-116.00K

-78.67%32.00K

732.61%291.00K

222.08%248.00K

--364.00K

194.12%150.00K

-64.29%-46.00K

48.08%77.00K

--0.00

-66.67%51.00K

---28.00K

-18.75%52.00K

-100.00%0.00

-68.19%153.00K

-100.00%0.00

-76.30%64.00K

--184.00K

--481.00K

--830.00K

--270.00K

----

Net cash flow from other financing activities

--0.00

----

100.00%0.00

----

---1.33M

---408.00K

---70.00K

----

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-678.13%-185.00K

-167.35%-196.00K

153.17%134.00K

-100.54%-116.00K

-99.23%32.00K

732.61%291.00K

-100.35%-252.00K

--21.38M

7998.04%4.13M

-64.29%-46.00K

138221.15%71.93M

--0.00

-66.67%51.00K

---28.00K

-18.75%52.00K

-100.00%0.00

-68.19%153.00K

-100.00%0.00

-76.30%64.00K

--184.00K

-99.78%481.00K

-99.01%830.00K

-99.39%270.00K

100.00%0.00

--213.84M

76.43%83.50M

787.53%44.26M

---70.00K

--0.00

--47.33M

--4.99M

Net cash flow

Beginning cash balance

-41.43%21.82M

30.68%31.69M

-8.37%30.82M

278.21%99.25M

-34.69%37.26M

-58.75%24.25M

-21.99%33.63M

-34.90%26.24M

60.76%57.04M

6.66%58.80M

-24.42%43.12M

-27.11%40.31M

-47.06%35.48M

15.27%55.13M

47.99%57.05M

260.80%55.30M

87.07%67.02M

-16.71%47.83M

-39.81%38.55M

-95.71%15.33M

-76.84%35.83M

-27.05%57.42M

61.29%64.04M

697.92%357.25M

199.50%154.72M

1070.64%78.71M

1001.97%39.70M

--44.77M

--51.66M

--6.72M

--3.60M

Current period cash flow changes

-85.35%9.08M

-175.91%-9.87M

109.32%874.00K

-1025.70%-68.43M

301.24%61.99M

841.87%13.01M

-159.83%-9.38M

163.34%7.39M

-738.27%-30.80M

91.08%-1.75M

918.00%15.68M

61.23%2.81M

141.18%4.83M

-202.34%-19.64M

-120.66%-1.92M

-92.50%1.74M

42.84%-11.72M

188.90%19.20M

240.19%9.28M

107.92%23.22M

-110.12%-20.50M

-128.41%-21.59M

-116.97%-6.62M

-5685.46%-293.21M

3040.26%202.53M

69.15%76.01M

1149.92%39.01M

---5.07M

---6.89M

--44.94M

--3.12M

Ending cash balance

-68.86%30.90M

-41.43%21.82M

30.68%31.69M

-8.37%30.82M

278.21%99.25M

-34.69%37.26M

-58.75%24.25M

-21.99%33.63M

-34.90%26.24M

60.76%57.04M

6.66%58.80M

-24.42%43.12M

-27.11%40.31M

-47.06%35.48M

15.27%55.13M

47.99%57.05M

260.80%55.30M

87.07%67.02M

-16.71%47.83M

-39.81%38.55M

-95.71%15.33M

-76.84%35.83M

-27.05%57.42M

61.29%64.04M

697.92%357.25M

199.50%154.72M

1070.64%78.71M

--39.70M

--44.77M

--51.66M

--6.72M

Free cash flow

-119.16%-10.23M

54.92%-6.79M

30.67%-7.85M

37.80%-9.16M

351.95%53.41M

-7.87%-15.05M

38.45%-11.32M

-2.49%-14.73M

-5.83%-21.20M

36.39%-13.96M

-11.65%-18.39M

21.31%-14.37M

29.98%-20.03M

10.01%-21.94M

42.91%-16.48M

29.80%-18.26M

-16.79%-28.61M

-53.49%-24.38M

-150.53%-28.86M

-91.38%-26.01M

-116.41%-24.50M

-111.41%-15.88M

-119.79%-11.52M

---13.59M

-64.33%-11.32M

-214.48%-7.51M

-180.87%-5.24M

----

---6.89M

---2.39M

---1.87M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Black Diamond Therapeutics Inc Generate?



Black Diamond Therapeutics Inc generated 29.61M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Black Diamond Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Black Diamond Therapeutics Inc's operating cash flow increased by 147.53% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Black Diamond Therapeutics Inc's Financing Cash Flow Changed?



Black Diamond Therapeutics Inc used -146.00K in financing activities in the latest quarter.

What is free cash flow and why does it matter for BDTX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Black Diamond Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was 29.61M reflecting a 147.53% change from the previous year.